These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27443696)

  • 1. Screening for Malignancy in Patients With Unprovoked Venous Thromboembolism: A Single-Center Retrospective Case Series.
    Barrett A; Kevane B; Hall P; Ní Áinle F; Breslin T
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):735-739. PubMed ID: 27443696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
    Coyle K; Carrier M; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Coyle D
    Thromb Res; 2017 Mar; 151():67-71. PubMed ID: 28160670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems.
    Robin P; Kumar S; Salaun PY; Le Roux PY; Couturaud F; Planquette B; Merah A; Roy PM; Thavorn K; Le Gal G
    Thromb Res; 2018 Nov; 171():97-102. PubMed ID: 30268859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unprovoked venous thromboembolism in women over 40: is screening for occult malignancy with mammography and abdominopelvic CT of benefit?
    Healy NA; Daley FC; Sinnatamby R
    Clin Radiol; 2020 Oct; 75(10):757-762. PubMed ID: 32646605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of unprovoked venous thromboembolism: a case for a tempered approach?
    Hussain TI; Stephenson JA; Das B; Naqvi S; Verma R; Barnes D
    Clin Radiol; 2016 Oct; 71(10):1005-1009. PubMed ID: 27237325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
    Alfonso A; Redondo M; Rubio T; Del Olmo B; Rodríguez-Wilhelmi P; García-Velloso MJ; Richter JA; Páramo JA; Lecumberri R
    Int J Cancer; 2013 Nov; 133(9):2157-64. PubMed ID: 23616232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting occult cancer screening in patients with unprovoked venous thromboembolism.
    Robin P; Carrier M
    Thromb Res; 2018 Apr; 164 Suppl 1():S7-S11. PubMed ID: 29703487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of additional abdominopelvic CT in detecting occult cancer in patients with unprovoked venous thromboembolism.
    Vaidyanathan S; Walsh J; Cliffe H; Saleem N; Weston MJ; Lowe AS; Chowdhury FU
    Clin Radiol; 2016 Jun; 71(6):501-6. PubMed ID: 27005017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of NICE recommendations on abdomino-pelvic CT, following unprovoked venous thromboembolism, in a UK teaching hospital: no additional detection of occult malignancy and high numbers of incidental findings.
    Garwood D; Renton BJ; Joekes E
    Acute Med; 2016; 15(5):25-9. PubMed ID: 27116584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography combined with computed tomography as a screening tool for occult malignancy in patients with unprovoked venous thromboembolism: an observational study.
    Chauchard M; Benali K; Papo T; Sacre K
    Medicine (Baltimore); 2014 Nov; 93(21):e110. PubMed ID: 25380083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism and occult cancer: impact on clinical practice.
    Gheshmy A; Carrier M
    Thromb Res; 2016 Apr; 140 Suppl 1():S8-11. PubMed ID: 27067984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
    Robin P; Le Roux PY; Le Moigne E; Planquette B; Prévot-Bitot N; Roy PM; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
    Thromb Res; 2017 Jul; 155():6-9. PubMed ID: 28460260
    [No Abstract]   [Full Text] [Related]  

  • 13. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
    Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
    Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.
    Robin P; Le Roux PY; Lacut K; Planquette B; Prévot-Bitot N; Lavigne C; Pastre J; Merah A; Le Gal G; Salaun PY
    PLoS One; 2017; 12(6):e0178849. PubMed ID: 28570648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism.
    Robin P; Otten HM; Delluc A; van Es N; Carrier M; Salaün PY; Le Gal G
    Thromb Res; 2018 Nov; 171():92-96. PubMed ID: 30268858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive Computed Tomography versus Limited Screening for Detection of Occult Cancer in Unprovoked Venous Thromboembolism: A Multicenter, Controlled, Randomized Clinical Trial.
    Prandoni P; Bernardi E; Valle FD; Visonà A; Tropeano PF; Bova C; Bucherini E; Islam MS; Piccioli A
    Semin Thromb Hemost; 2016 Nov; 42(8):884-890. PubMed ID: 27764880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions.
    Patel SS; Tao D; McMurry HS; Shatzel JJ
    Eur J Haematol; 2023 Jan; 110(1):24-31. PubMed ID: 36192850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Occult Cancer in Unprovoked Venous Thromboembolism.
    Carrier M; Lazo-Langner A; Shivakumar S; Tagalakis V; Zarychanski R; Solymoss S; Routhier N; Douketis J; Danovitch K; Lee AY; Le Gal G; Wells PS; Corsi DJ; Ramsay T; Coyle D; Chagnon I; Kassam Z; Tao H; Rodger MA;
    N Engl J Med; 2015 Aug; 373(8):697-704. PubMed ID: 26095467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT imaging for occult malignancy in patients with unprovoked venous thromboembolism (VTE) in a tertiary centre: is it worthwhile?
    Lee RJ; Herlihy D; O'Neill DC; Madden-Doyle L; Morrin M; Lee MJ
    Ir J Med Sci; 2023 Dec; 192(6):3081-3086. PubMed ID: 36849651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
    Han D; ó Hartaigh B; Lee JH; Cho IJ; Shim CY; Chang HJ; Hong GR; Ha JW; Chung N
    PLoS One; 2016; 11(4):e0153514. PubMed ID: 27073982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.